Sebia and METAFORA biosystems form strategic partnership to develop advanced in vitro diagnostics
September 16, 2021
48th SENP Lausanne
March 29, 2022
3rd February 2022 – SFNP Congress
We are delighted to have been able to participate in the 31st congress of the SOCIETE FRANCAISE DE NEUROLOGIE PEDIATRIQUE (SFNP) to present the results of the validation study of our METAglut1 test aimed at improving the early diagnosis of De Vivo’s disease.
